Nutrigenomics Research Group, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Tarragona, 43007, Spain.
Mol Nutr Food Res. 2022 Nov;66(21):e2100990. doi: 10.1002/mnfr.202100990. Epub 2022 Mar 28.
Cardiovascular diseases (CVD) are the leading cause of deaths worldwide and their prevalence is continuously increasing. Available treatments may present several side effects and therefore the development of new safer therapeutics is of interest. Phenolic compounds have shown several cardioprotective properties helpful in reducing different CVD risk factors such as inflammation, elevated blood pressure, hyperlipidemia, or endothelial dysfunction. These factors are significantly influenced by biological rhythms which are in fact emerging as key modulators of important metabolic and physiological processes. Thus, increased events of CVD have been observed under circadian rhythm disruption or in winter versus other seasons. These rhythms can also affect the functionality of phenolic compounds. Indeed, different effects have been observed depending on the administration time or under different photoperiods. Therefore, in this review the focus will be on the potential of phenolic compounds as therapeutics to prevent CVD via biological rhythm modulation.
心血管疾病 (CVD) 是全球范围内导致死亡的主要原因,其发病率持续上升。现有的治疗方法可能会带来一些副作用,因此开发更安全的新疗法很有意义。酚类化合物具有多种心脏保护特性,有助于降低不同的 CVD 风险因素,如炎症、血压升高、高血脂或内皮功能障碍。这些因素受生物节律的显著影响,而生物节律实际上是许多重要代谢和生理过程的关键调节剂。因此,在昼夜节律紊乱或冬季与其他季节相比时,CVD 事件的发生率会增加。这些节律也会影响酚类化合物的功能。事实上,根据给药时间或不同的光周期,观察到的效果也不同。因此,在本综述中,重点将放在通过调节生物节律来利用酚类化合物作为治疗剂预防 CVD 的潜力上。